Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing nitazoxanide as a novel anti‐atherosclerotic drug based on mitochondrial uncoupling mechanisms
Ma Minghui, Fengfeng Li, Wenfeng Li, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 1, pp. 62-79
Open Access | Times Cited: 20

Showing 20 citing articles:

The role of AMPK in macrophage metabolism, function and polarisation
Yinxing Cui, Junhua Chen, Zhao Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Mitochondrial Dynamics and Metabolism in Macrophages for Cardiovascular Disease: a review
Yi-lang Zhong, Chenqin Xu, Ji Li, et al.
Phytomedicine (2025) Vol. 140, pp. 156620-156620
Closed Access | Times Cited: 1
Targeting mitochondrial function in macrophages: A novel treatment strategy for atherosclerotic cardiovascular disease?
Pierre Hadrien Becker, Patrice Thérond, Pauline Gaignard
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108441-108441
Open Access | Times Cited: 14
Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME “two-hit” in mice
Jiahui Chen, Liping Zhang, Ting Xie, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease
Weiqian E. Lee, Elijah Genetzakis, Gemma A. Figtree
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1359-1359
Open Access | Times Cited: 10
Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis
Xuyang Chen, Yan‐Chao Dong, Yuanyuan Yu, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 23, pp. 3008-3023
Closed Access | Times Cited: 10
The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan
Wenfeng Li, Shuming Chen, Jing Lang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3266-3280
Open Access | Times Cited: 3
The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice
Kaixin Liu, Z.R. Wang, Yiwei Ying, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116205-116205
Closed Access | Times Cited: 3
The repurposing of Nitazoxanide for psoriasis treatment exerts therapeutic effects through skin metabolic reprogramming
Jong Yeong Lee, Ha Eun Kim, Seung Taek Lee, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Combining RNA-seq, molecular docking and experimental verification to explore the mechanism of BAM15 as a potential drug for atherosclerosis
Minghui Ma, Jiao Zhong, Yu Tai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation
Hu-Tai-Long Zhu, Jing Luo, Yi Peng, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111013-111013
Closed Access | Times Cited: 2
Single‐cell sequencing combined with transcriptomics and in vivo and in vitro analysis reveals the landscape of ferroptosis in myocardial ischemia–reperfusion injury
Chongning Zhong, Hui Dong, Yuting Ma, et al.
The FASEB Journal (2024) Vol. 38, Iss. 21
Open Access | Times Cited: 2
Sorafenib extends the lifespan of C. elegans through mitochondrial uncoupling mechanism
Luyao Zheng, Yan-Xin Da, Xiu Luo, et al.
Free Radical Biology and Medicine (2024) Vol. 214, pp. 101-113
Closed Access | Times Cited: 1
Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress
Nevertyty M. Mahmoud, Shimaa M. Elshazly, Fatma El-shaarawy, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Nitazoxanide ameliorates OVA-induced airway inflammation in asthmatic mice via p38-MAPK/NFkB and AMPK/STAT3 pathways
Zhuyun Huang, Yi Zhang, Yudi Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joint Screening and Identification of Potential Targets of Nitazoxanide by Affinity Chromatography and Label-Free Techniques
Menghan Zhu, Dongxia Qi, Dongliang Chen, et al.
Current Drug Targets (2024) Vol. 25, Iss. 12, pp. 819-845
Closed Access
Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome
Bernardo Gindri dos Santos, Niki F. Brisnovali, Leigh Goedeke
Biochemical Journal (2024) Vol. 481, Iss. 23, pp. 1831-1854
Closed Access
Nitazoxanide alleviates experimental pulmonary fibrosis by inhibiting the development of cellular senescence
Xianzhe Wang, Yanyan Zhu, Huilin Liu, et al.
Life Sciences (2024) Vol. 361, pp. 123302-123302
Closed Access
Tizoxanide as a novel theraputic candidate for osteoarthritis
Bowei Ni, Jiyuan Yan, Wenxiang Cai, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19472-e19472
Open Access | Times Cited: 1
Asprosin aggravates atherosclerosis via regulating the phenotype transformation of vascular smooth muscle cells
Yu Zhao, Zheng-kai Wang, Yi Chen, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131868-131868
Closed Access
Page 1

Scroll to top